ZYME - Zymeworks Common Stock - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ZYME is currently covered by 10 analysts with an average price target of $40.39. This is a potential upside of $14.6 (56.61%) from yesterday's end of day stock price of $25.79.

Zymeworks Common Stock's activity chart (see below) currently has 156 price targets and 152 ratings on display. The stock rating distribution of ZYME is 87.8% BUY and 12.2% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.28% with an average time for these price targets to be met of 230.17 days.

Highest price target for ZYME is $58, Lowest price target is $23, average price target is $40.39.

Most recent stock forecast was given by GREGORY RENZA from TRUIST. First documented stock forecast 23-May-2017.

Currently out of the existing stock ratings of ZYME, 36 are a BUY (87.8%), 5 are a HOLD (12.2%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Jul-2026

$34

$8.21 (31.83%)

$32

Buy Since 28-Feb-2022

$39

$13.21 (51.22%)

$38

11 days ago
(29-Sep-2026)

15/20 (75%)

$11.8 (43.38%)

508

Buy Since 03-Dec-2025

$32

$6.21 (24.08%)

$32

1 months 14 days ago
(26-Aug-2026)

0/5 (0%)

$2.69 (9.18%)

Buy Since 18-Nov-2025

$55

$29.21 (113.26%)

$51

1 months 14 days ago
(26-Aug-2026)

18/25 (72%)

$25.69 (87.65%)

69

Buy Since 10-Oct-2025

$44

$18.21 (70.61%)

$40

2 months ago
(10-Aug-2026)

1/4 (25%)

$19.84 (82.12%)

327

Show more analysts

Please expand the browser size to see the chart

What is ZYME (Zymeworks Common Stock) average time for price targets to be met?

On average it took 230 days for the stock forecasts to be reached, with an average price target met ratio of 62.28%.

Which analyst most recently updated their price target on ZYME (Zymeworks Common Stock)?

Gregory Renza

Which analyst has the most public recommendations on ZYME (Zymeworks Common Stock)?

Gregory Renza works at TRUIST and has 7 price targets and 4 ratings on ZYME

Which analyst is the currently most bullish on ZYME (Zymeworks Common Stock)?

David Novak with the highest potential upside of $48.21

Which analyst is the currently most reserved on ZYME (Zymeworks Common Stock)?

Gena Wang with the lowest potential downside of -$16.79
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?